Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT screenings for those eligible – the disease can be completely curable.

Racial disparities persist in receipt of curative treatment for early-stage non-small cell lung cancer (NSCLC), according to ...

A new study finds Black Medicare beneficiaries with early-stage non–small cell lung cancer (NSCLC) continues to receive curative treatment at lower rates than White patients, highlighting ongoing ...

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.

The past 30 years have seen tremendous progress in our fundamental understanding of lung cancer and the development of new treatment strategies,” senior researcher Dr. Cary Gross, a professor at Yale ...

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...

February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...

In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...

Researchers looked for incidence of multiple types of cancer in 417,984 Australian women who used medically assisted reproduction from 1991 to 2018.

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

EVERY day without a dedicated PhilHealth Z Benefit Package for lung cancer means more Filipino families face delayed ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...